Treatment of irritant contact dermatitis in healthcare settings during the COVID19 pandemic: The emollient Dermol 500 exhibits virucidal activity against influenza A virus and SARS-CoV-2

Christine T. Styles, Michael Vanden Oever, Jonathan Brown, Sweta Rai, Sarah Walsh, Finola M. Ryan, Wendy S. Barclay, Rachel S. Edgar
doi: https://doi.org/10.1101/2021.02.12.21251419

Article usage

Article usage: February 2021 to June 2025

AbstractFullPdf
Feb 20218613483
Mar 202142186874
Apr 202116436147
May 202120822122
Jun 20211298101
Jul 2021781153
Aug 2021901633
Sep 2021821045
Oct 20211071236
Nov 2021691973
Dec 2021102840
Jan 202247839
Feb 2022864222
Mar 2022691038
Apr 2022901444
May 2022551226
Jun 20224617157
Jul 2022516141
Aug 2022581261
Sep 202256825
Oct 20221611437
Nov 2022321816
Dec 202226822
Jan 2023381023
Feb 2023371123
Mar 2023371624
Apr 202333512
May 202344530
Jun 202328824
Jul 202320109
Aug 2023401324
Sep 2023311916
Oct 202318412
Nov 2023382422
Dec 20232669
Jan 2024431014
Feb 202432825
Mar 202422931
Apr 2024312044
May 202427824
Jun 202426422
Jul 202426324
Aug 202442924
Sep 202434323
Oct 202423525
Nov 202422829
Dec 202421834
Jan 2025391847
Feb 2025272838
Mar 2025414649
Apr 2025792053
May 2025696363
Jun 2025161311
Back to top
Posted March 11, 2021.
Download PDF
Data/Code
Email
Treatment of irritant contact dermatitis in healthcare settings during the COVID19 pandemic: The emollient Dermol 500 exhibits virucidal activity against influenza A virus and SARS-CoV-2
Christine T. Styles, Michael Vanden Oever, Jonathan Brown, Sweta Rai, Sarah Walsh, Finola M. Ryan, Wendy S. Barclay, Rachel S. Edgar
medRxiv 2021.02.12.21251419; doi: https://doi.org/10.1101/2021.02.12.21251419
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area